APELLIS PHARMACEUTICALS INC's ticker is APLS and the CUSIP is 03753U106. A total of 281 filers reported holding APELLIS PHARMACEUTICALS INC in Q1 2023. The put-call ratio across all filers is 0.61 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $159,958,200 | -32.9% | 4,205,000 | +60.6% | 24.58% | -26.0% |
| Q2 2023 | $238,527,130 | +11.3% | 2,618,300 | -19.4% | 33.19% | +7.6% |
| Q1 2023 | $214,370,000 | +31.2% | 3,250,000 | +2.8% | 30.84% | +21.2% |
| Q4 2022 | $163,403,600 | -4.4% | 3,160,000 | +26.2% | 25.44% | -13.8% |
| Q3 2022 | $170,959,000 | +46.4% | 2,503,059 | -3.1% | 29.50% | -5.4% |
| Q2 2022 | $116,806,000 | -1.8% | 2,583,059 | +10.4% | 31.17% | +21.3% |
| Q1 2022 | $118,898,000 | +24.4% | 2,340,059 | +15.8% | 25.70% | +38.2% |
| Q4 2021 | $95,549,000 | +81.6% | 2,020,911 | +26.6% | 18.59% | +43.6% |
| Q3 2021 | $52,601,000 | -33.7% | 1,595,911 | +27.0% | 12.95% | -21.2% |
| Q2 2021 | $79,396,000 | +237.4% | 1,256,265 | +129.1% | 16.44% | +85.5% |
| Q1 2021 | $23,531,000 | -25.0% | 548,374 | 0.0% | 8.86% | -18.5% |
| Q4 2020 | $31,367,000 | – | 548,374 | – | 10.87% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| AJU IB Investment Co., Ltd. | 1,114,962 | $63,776,000 | 24.13% |
| Octagon Capital Advisors LP | 548,374 | $31,367,000 | 10.87% |
| Ghost Tree Capital, LLC | 325,000 | $18,590,000 | 4.14% |
| Burrage Capital Management LLC | 81,357 | $4,654,000 | 3.55% |
| Aufman Associates Inc | 53,642 | $3,068,000 | 2.75% |
| ACUTA CAPITAL PARTNERS, LLC | 167,054 | $9,555,000 | 2.60% |
| Cormorant Asset Management, LP | 1,866,108 | $106,741,000 | 2.54% |
| Tri Locum Partners LP | 121,409 | $6,945,000 | 2.52% |
| venBio Partners LLC | 490,471 | $28,055,000 | 2.48% |
| HHLR ADVISORS, LTD. | 5,028,289 | $287,618,000 | 2.29% |